Claroid Pharmaceuticals Ltd.
NSE & BSETBA
TBA
1 Shares
TBA
₹10
Subscription Details
IPO Timeline
IPO Offer Start
TBA
IPO Offer Ends
TBA
TBA
Use of Proceeds
| # | Purpose | Amount (₹ Million) |
|---|---|---|
| 1 | Funding of capital expenditure requirement for setting up of the Proposed Plant | 1,679.678 |
Promoters
Book Running Lead Managers
Promoter Shareholding
Pre-IPO
100.00%
Promoter stake
Offered to Public
1,26,00,000
shares
About the Company
We are a pharmaceutical formulations manufacturing company engaged in the development and manufacture of generic pharmaceutical products, comprising tablets and ointments and the encapsulation of pharmaceuticals formulations into hard gelatin capsules. Our business model is primarily focused on export of pharmaceutical products to semi-regulated international markets, particularly in Africa.
Use of Proceeds
1. Funding of capital expenditure requirement for setting up of the Proposed Plant; and2. General Corporate purposes.
Claroid Pharmaceuticals Ltd. Latest News
News
No news found for Claroid Pharmaceuticals Ltd..
IPO FAQs
The for the Claroid Pharmaceuticals Ltd. IPO is 1 shares, which is also the minimum order quantity — you have to apply for at least 1 shares, and in multiples of 1 beyond that.